Alba Therapeutics

Modulating cellular tight junctions to treat autoimmune, immune-mediated and inflammatory diseases.

placeBaltimore, Maryland, United States calendar_todayFounded 2004 groups38 employees language albatherapeutics.com

Registered entities

Innovation

24 patent families (12 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 954 times.

YearFilings
20125
20137
20146
20156
20167
20173
20184
20191
20203
20213
20221

Investor mix

9 investors on record; lead investors include SV Health Investors.

Investor typeCountShare
Venture capital889%
Private equity111%
Coming soon